title: Autoimmune disorders and interleukin-2 therapy: a step toward 'unanswered questions'.
authors.forename: P
authors.initials: P
authors.lastname: Wolkenstein
authors.forename: J
authors.initials: J
authors.lastname: Revuz
authors.forename: J C
authors.initials: JC
authors.lastname: Guillaume
authors.forename: M F
authors.initials: MF
authors.lastname: Avril
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
mesh_terms: D001327:Autoimmune Diseases / Q000209:etiology*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000628:therapy; D008875:Middle Aged; D010392:Pemphigus / Q000209:etiology / Q000276:immunology; D012878:Skin Neoplasms / Q000628:therapy; D014820:Vitiligo / Q000209:etiology / Q000276:immunology
chemical_list: D007376:Interleukin-2